Alkem Laboratories Ltd.
|
Income Statement
|
|
You can view the
Income Statement
for the last 5 years.
Market Cap. (Rs.)
|
65022.44 Cr.
|
P/BV
|
7.19
|
Book Value (Rs.)
|
756.52
|
52 Week High/Low (Rs.)
|
5520/3186
|
FV/ML
|
2/1
|
P/E(X)
|
66.07
|
Bookclosure
|
17/02/2024
|
EPS (Rs.)
|
82.31
|
Div Yield (%)
|
0.92
|
|
(Rs. in Crs.)
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| | | | | |
| | | | | |
INCOME | | | | | |
Revenue From Operations [Net] | 11440.35 | 10634.19 | 8728.40 | 8191.96 | 7265.85 |
Other Operating Revenues | 158.91 | 0.00 | 136.61 | 152.40 | 91.34 |
Total Operating Revenues | 11599.26 | 10634.19 | 8865.01 | 8344.36 | 7357.19 |
| | | | | |
Other Income | 216.08 | 162.65 | 233.21 | 104.22 | 87.70 |
Total Revenue | 11815.34 | 10796.84 | 9098.22 | 8448.58 | 7444.89 |
| | | | | |
EXPENSES | | | | | |
Cost Of Materials Consumed | 3056.92 | 3226.06 | 2394.54 | 2131.83 | 1811.14 |
Purchase Of Stock-In Trade | 1387.55 | 1489.71 | 1437.76 | 1443.06 | 1130.19 |
Changes In Inventories Of FG,WIP And Stock-In Trade | 462.37 | -535.48 | -333.84 | -229.95 | 3.64 |
Employee Benefit Expenses | 2131.35 | 1962.71 | 1621.03 | 1505.49 | 1362.46 |
Finance Costs | 107.36 | 52.37 | 58.92 | 65.06 | 54.63 |
Depreciation And Amortisation Expenses | 310.42 | 303.96 | 274.58 | 252.76 | 193.18 |
Other Expenses | 2951.62 | 2438.27 | 1803.13 | 2020.54 | 1934.99 |
Total Expenses | 10407.59 | 8937.60 | 7256.12 | 7188.79 | 6490.23 |
| | | | | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 1407.75 | 1859.24 | 1842.10 | 1259.79 | 954.66 |
| | | | | |
Exceptional Items | -102.98 | -14.96 | 0.00 | 0.00 | 0.00 |
Profit/Loss Before Tax | 1304.77 | 1844.28 | 1842.10 | 1259.79 | 954.66 |
| | | | | |
Tax Expenses-Continued Operations | | | | | |
Current Tax | 273.90 | 361.98 | 396.53 | 354.25 | 229.17 |
Deferred Tax | 24.06 | -198.02 | -172.20 | -212.39 | -48.15 |
Tax For Earlier Years | 0.00 | 0.00 | 0.00 | -31.38 | 0.00 |
Total Tax Expenses | 297.96 | 163.96 | 224.33 | 110.48 | 181.02 |
Profit/Loss After Tax And Before ExtraOrdinary Items | 1006.81 | 1680.32 | 1617.77 | 1149.31 | 773.64 |
| | | | | |
Profit/Loss From Continuing Operations | 1006.81 | 1680.32 | 1617.77 | 1149.31 | 773.64 |
| | | | | |
Profit/Loss For The Period | 1006.81 | 1680.32 | 1617.77 | 1149.31 | 773.64 |
| | | | | |
Minority Interest | -22.64 | -34.70 | -32.75 | -22.24 | -13.13 |
Consolidated Profit/Loss After MI And Associates | 984.17 | 1645.62 | 1585.02 | 1127.07 | 760.51 |
| | | | | |
OTHER INFORMATION | | | | | |
| | | | | |
EARNINGS PER SHARE | | | | | |
Basic EPS (Rs.) | 82.31 | 137.63 | 132.57 | 94.26 | 63.61 |
Diluted EPS (Rs.) | 82.31 | 137.63 | 132.57 | 94.26 | 63.61 |
| | | | | |
DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
Equity Share Dividend | 526.09 | 0.00 | 334.78 | 358.70 | 179.35 |
Tax On Dividend | 0.00 | 0.00 | 0.00 | 74.38 | 37.28 |